Literature DB >> 22661456

Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.

Wanyin Deng1, Hong B Yu, Carmen L de Hoog, Nikolay Stoynov, Yuling Li, Leonard J Foster, B Brett Finlay.   

Abstract

Type III secretion systems are central to the pathogenesis and virulence of many important Gram-negative bacterial pathogens, and elucidation of the secretion mechanism and identification of the secreted substrates are critical to our understanding of their pathogenic mechanisms and developing potential therapeutics. Stable isotope labeling with amino acids in cell culture-based mass spectrometry is a quantitative and highly sensitive proteomics tool that we have previously used to successfully analyze the type III secretomes of Citrobacter rodentium and Salmonella enterica serovar Typhimurium. In this report, stable isotope labeling with amino acids in cell culture was used to analyze the type III secretome of enteropathogenic Escherichia coli (EPEC), an important human pathogen, which, together with enterohemorrhagic E. coli and C. rodentium, represents the family of attaching and effacing bacterial pathogens. We not only confirmed all 25 known EPEC type III-secreted proteins and effectors previously identified by conventional molecular and bioinformatical techniques but also identified several new type III-secreted proteins, including two novel effectors, C_0814/NleJ and LifA, that were shown to be translocated into host cells. LifA is a known virulence factor believed to act as a toxin as well as an adhesin, but its mechanism of secretion and function is not understood. With a predicted molecular mass of 366 kDa, LifA is the largest type III effector identified thus far in any pathogen. We further demonstrated that Efa1, ToxB, and Z4332 (homologs of LifA in enterohemorrhagic E. coli) are also type III effectors. This study has comprehensively characterized the type III secretome of EPEC, expanded the repertoire of type III-secreted effectors for the attaching and effacing pathogens, and provided new insights into the mode of function for LifA/Efa1/ToxB/Z4332, an important family of virulence factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661456      PMCID: PMC3434768          DOI: 10.1074/mcp.M111.013672

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  57 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 2.  Citrobacter rodentium of mice and man.

Authors:  Rosanna Mundy; Thomas T MacDonald; Gordon Dougan; Gad Frankel; Siouxsie Wiles
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

3.  Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression.

Authors:  R A Edwards; L H Keller; D M Schifferli
Journal:  Gene       Date:  1998-01-30       Impact factor: 3.688

Review 4.  Common themes in microbial pathogenicity revisited.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

5.  Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo.

Authors:  Jan-Michael A Klapproth; Maiko Sasaki; Melanie Sherman; Brian Babbin; Michael S Donnenberg; Paula J Fernandes; Isabel C A Scaletsky; Daniel Kalman; Asma Nusrat; Ifor R Williams
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens.

Authors:  Wanyin Deng; Yuling Li; Philip R Hardwidge; Elizabeth A Frey; Richard A Pfuetzner; Sansan Lee; Samantha Gruenheid; Natalie C J Strynakda; Jose L Puente; B Brett Finlay
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Genetic and biochemical characterization of Citrobacter rodentium sp. nov.

Authors:  D B Schauer; B A Zabel; I F Pedraza; C M O'Hara; A G Steigerwalt; D J Brenner
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

8.  Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production.

Authors:  J M Klapproth; M S Donnenberg; J M Abraham; H L Mobley; S P James
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 9.  Attaching-effacing bacteria in animals.

Authors:  A D Wales; M J Woodward; G R Pearson
Journal:  J Comp Pathol       Date:  2005-01       Impact factor: 1.311

10.  An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination.

Authors:  Toru Tobe; Scott A Beatson; Hisaaki Taniguchi; Hiroyuki Abe; Christopher M Bailey; Amanda Fivian; Rasha Younis; Sophie Matthews; Olivier Marches; Gad Frankel; Tetsuya Hayashi; Mark J Pallen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-21       Impact factor: 11.205

View more
  37 in total

1.  SepD/SepL-dependent secretion signals of the type III secretion system translocator proteins in enteropathogenic Escherichia coli.

Authors:  Wanyin Deng; Hong B Yu; Yuling Li; B Brett Finlay
Journal:  J Bacteriol       Date:  2015-02-02       Impact factor: 3.490

2.  A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.

Authors:  Víctor A García-Angulo; Verónica I Martínez-Santos; Tomás Villaseñor; Francisco J Santana; Alejandro Huerta-Saquero; Luary C Martínez; Rafael Jiménez; Cristina Lara-Ochoa; Juan Téllez-Sosa; Víctor H Bustamante; José L Puente
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

3.  Secretome analysis of diarrhea-inducing strains of Escherichia coli.

Authors:  Raja Sekhar Nirujogi; Babylakshmi Muthusamy; Min-Sik Kim; Gajanan J Sathe; P T V Lakshmi; Olga N Kovbasnjuk; T S Keshava Prasad; Mary Wade; Rabih E Jabbour
Journal:  Proteomics       Date:  2017-03-06       Impact factor: 3.984

4.  Citrobacter Infection and Wnt signaling.

Authors:  Shahid Umar
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

5.  Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome.

Authors:  Eduardo Soto; Norma Espinosa; Miguel Díaz-Guerrero; Meztlli O Gaytán; José L Puente; Bertha González-Pedrajo
Journal:  J Bacteriol       Date:  2016-12-13       Impact factor: 3.490

6.  Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis.

Authors:  Roland Scholz; Koshi Imami; Nichollas E Scott; William S Trimble; Leonard J Foster; B Brett Finlay
Journal:  Mol Cell Proteomics       Date:  2015-05-05       Impact factor: 5.911

Review 7.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

9.  Role of EscP (Orf16) in injectisome biogenesis and regulation of type III protein secretion in enteropathogenic Escherichia coli.

Authors:  Julia Monjarás Feria; Elizabeth García-Gómez; Norma Espinosa; Tohru Minamino; Keiichi Namba; Bertha González-Pedrajo
Journal:  J Bacteriol       Date:  2012-08-24       Impact factor: 3.490

10.  Comparative Secretome Analysis of Ralstonia solanacearum Type 3 Secretion-Associated Mutants Reveals a Fine Control of Effector Delivery, Essential for Bacterial Pathogenicity.

Authors:  Fabien Lonjon; Marie Turner; Céline Henry; David Rengel; David Lohou; Quitterie van de Kerkhove; Anne-Claire Cazalé; Nemo Peeters; Stéphane Genin; Fabienne Vailleau
Journal:  Mol Cell Proteomics       Date:  2015-12-03       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.